These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 18672973)
1. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973 [TBL] [Abstract][Full Text] [Related]
2. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674 [TBL] [Abstract][Full Text] [Related]
3. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Vinall RL; Kent MS; deVere White RW Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder. Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385 [TBL] [Abstract][Full Text] [Related]
6. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma. Walters L; Martin O; Price J; Sula MM Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928 [TBL] [Abstract][Full Text] [Related]
7. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612 [TBL] [Abstract][Full Text] [Related]
8. Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma. Finotello R; Schiavo L; Ressel L; Frohmader A; Silvestrini P; Verin R J Comp Pathol; 2019 Jul; 170():1-9. PubMed ID: 31375151 [TBL] [Abstract][Full Text] [Related]
9. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma. Ham WS; Lee JH; Yu HS; Choi YD Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas. Kitsukawa S; Aoyagi T; Noda K; Ito T; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T Hinyokika Kiyo; 2008 Feb; 54(2):101-6. PubMed ID: 18323166 [TBL] [Abstract][Full Text] [Related]
11. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N Urol J; 2009; 6(2):101-8. PubMed ID: 19472128 [TBL] [Abstract][Full Text] [Related]
12. H-ras immunohistochemical expression and molecular analysis of urinary bladder lesions in grazing adult cattle exposed to bracken fern. Sardon D; de la Fuente I; Calonge E; Perez-Alenza MD; Castaño M; Dunner S; Peña L J Comp Pathol; 2005; 132(2-3):195-201. PubMed ID: 15737346 [TBL] [Abstract][Full Text] [Related]
13. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Schultz IJ; Kiemeney LA; Witjes JA; Schalken JA; Willems JL; Swinkels DW; de Kok JB Anticancer Res; 2003; 23(4):3327-31. PubMed ID: 12926071 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030 [TBL] [Abstract][Full Text] [Related]
15. Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008). Childress MO; Adams LG; Ramos-Vara JA; Freeman LJ; He S; Constable PD; Knapp DW J Am Vet Med Assoc; 2011 Aug; 239(3):350-6. PubMed ID: 21801049 [TBL] [Abstract][Full Text] [Related]
16. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder. Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor expression in canine transitional cell carcinoma. Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Lehner R; Lucia MS; Jarboe EA; Orlicky D; Shroyer AL; McGregor JA; Shroyer KR Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):134-8. PubMed ID: 12051631 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples. Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer. Atlasi Y; Mowla SJ; Ziaee SA Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]